Berberine chloride dihydrateCAS# 5956-60-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 5956-60-5 | SDF | Download SDF |
| PubChem ID | 160800 | Appearance | Yellow powder |
| Formula | C20H22ClNO6 | M.Wt | 407.8 |
| Type of Compound | Nitrogen-containing Compounds | Storage | Desiccate at -20°C |
| Solubility | Sparingly soluble in water; practically insoluble in ethan | ||
| Chemical Name | 16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride;dihydrate | ||
| SMILES | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.O.[Cl-] | ||
| Standard InChIKey | NWMNHQUPWGJEKI-UHFFFAOYSA-M | ||
| Standard InChI | InChI=1S/C20H18NO4.ClH.2H2O/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;;;/h3-4,7-10H,5-6,11H2,1-2H3;1H;2*1H2/q+1;;;/p-1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Berberine chloride dihydrate Dilution Calculator
Berberine chloride dihydrate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.4522 mL | 12.2609 mL | 24.5218 mL | 49.0436 mL | 61.3046 mL |
| 5 mM | 0.4904 mL | 2.4522 mL | 4.9044 mL | 9.8087 mL | 12.2609 mL |
| 10 mM | 0.2452 mL | 1.2261 mL | 2.4522 mL | 4.9044 mL | 6.1305 mL |
| 50 mM | 0.049 mL | 0.2452 mL | 0.4904 mL | 0.9809 mL | 1.2261 mL |
| 100 mM | 0.0245 mL | 0.1226 mL | 0.2452 mL | 0.4904 mL | 0.613 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ballonigrine
Catalog No.:BCN0303
CAS No.:62340-62-9
- Bakuchicin
Catalog No.:BCN0302
CAS No.:4412-93-5
- Avenanthramide D
Catalog No.:BCN0301
CAS No.:115610-36-1
- Atropine N-oxide hydrochloride
Catalog No.:BCN0300
CAS No.:4574-60-1
- Apoatropine hydrochloride
Catalog No.:BCN0299
CAS No.:5978-81-4
- (-)-Antofine
Catalog No.:BCN0298
CAS No.:32671-82-2
- Anisodine hydrobromide
Catalog No.:BCN0297
CAS No.:76822-34-9
- Anemonin
Catalog No.:BCN0296
CAS No.:508-44-1
- Andrograpanin
Catalog No.:BCN0295
CAS No.:82209-74-3
- L-(±)-Alliin
Catalog No.:BCN0294
CAS No.:17795-26-5
- Procyanidin A4
Catalog No.:BCN0293
CAS No.:111466-29-6
- Ergocornine
Catalog No.:BCN0292
CAS No.:564-36-3
- Californidine perchlorate
Catalog No.:BCN0305
CAS No.:17939-31-0
- Cannflavin A
Catalog No.:BCN0306
CAS No.:76735-57-4
- Castalagin
Catalog No.:BCN0307
CAS No.:24312-00-3
- (-)-Catechin
Catalog No.:BCN0308
CAS No.:18829-70-4
- Convolidine
Catalog No.:BCN0309
CAS No.:63911-32-0
- trans-p-Coumaric acid
Catalog No.:BCN0310
CAS No.:501-98-4
- trans-Coutaric acid
Catalog No.:BCN0311
CAS No.:27174-07-8
- Cycloartenol
Catalog No.:BCN0312
CAS No.:469-38-5
- 5,6-Dehydro 7,8-dihydrokavain
Catalog No.:BCN0313
CAS No.:3155-51-9
- 23-epi-26-Deoxyactein
Catalog No.:BCN0314
CAS No.:501938-01-8
- Dihydroavenanthramide D
Catalog No.:BCN0315
CAS No.:697235-49-7
- 2',6'-Dihydroxy 4',4-dimethoxychalcone
Catalog No.:BCN0316
CAS No.:94441-99-3
Developmental toxicity evaluation of berberine in rats and mice.[Pubmed:16634078]
Birth Defects Res B Dev Reprod Toxicol. 2006 Jun;77(3):195-206.
BACKGROUND: Berberine, a plant alkaloid, is found in some herbal teas and health-related products. It is a component of goldenseal, an herbal supplement. Berberine chloride dihydrate (BCD) was evaluated for developmental toxicity in rats and mice. METHODS: Berberine chloride dihydrate was administered in the feed to timed-mated Sprague-Dawley (CD) rats (0, 3,625, 7,250, or 14,500 ppm; on gestational days [GD] 6-20), and Swiss Albino (CD-1) mice (0, 3,500, 5,250, or 7,000 ppm; on GD 6-17). Ingested doses were 0, 282, 531, and 1,313 mg/kg/day (rats) and 0, 569, 841, and 1,155 mg/kg/day (mice). RESULTS: There were no maternal deaths. The rat maternal lowest observed adverse effect level (LOAEL), based on reduced maternal weight gain, was 7,250 ppm. The rat developmental toxicity LOAEL, based on reduced fetal body weight per litter, was 14,500 ppm. In the mouse study, equivocal maternal and developmental toxicity LOAELs were 5,250 ppm. Due to scattering of feed in the high dose groups, a gavage study at 1,000 mg/kg/day was conducted in both species. CONCLUSIONS: In rats, maternal, but not fetal adverse effects were noted. The maternal toxicity LOAEL remained at 7,250 ppm (531 mg/kg/day) based on the feed study and the developmental toxicity NOAEL was raised to 1,000 mg/kg/day BCD based on the gavage study. In the mouse, 33% of the treated females died. Surviving animals had increased relative water intake, and average fetal body weight per litter decreased 5-6% with no change in live litter size. The maternal toxicity LOAEL remained at 5,250 ppm (841 mg/kg/day) BCD, based on increased water consumption. The developmental toxicity LOAEL was raised to 1,000 mg/kg/day BCD based on decreased fetal body weight.
